Clinical trials

Durvalumab (MEDI4736) After chemoRadioTherapy for NSCLC patients
– a phase II translational and biomarker study investigating PDL1 positive and negative patients

More information

Nivolumab and Ipilimumab +/- UV1 vaccination as second line treatment in patients with malignant mesothelioma
– a phase II randomised clinical and translational trial

More information

Immunotherapy combined with extensive radiotherapy for the treatment of stage IV non-small cell lung cancer (COM-IT-2)
– a phase II randomised clinical and translational trial

More information

Norwegian Pancreatic Cancer Trial (NorPACT)-2:
Liquid biopsies and blood-based biomarkers
https://norpact.com


MATRIX-RARE – Precision cancer medicine in hard-to-treat rare cancers - repurposing drugs in earlier lines of treatment; matrixrare.no 

More information

IMPRESS-Norway – A multi-cohort phase 2 treatment clinical study investigating efficacy of approved drugs outside indication in patients with advanced cancer. Homepage: IMPRESS-Norway

More information
 
Scroll to top